Summit Therapeutics, Inc. (SMMT)
12.90
-1.39
(-9.73%)
USD |
NASDAQ |
Jun 10, 15:32
Summit Therapeutics EPS Diluted (Quarterly) : -0.2443 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -2.291 |
| Denali Therapeutics, Inc. | -0.6882 |
| NovelStem International Corp. | -0.0012 |
| Brainstorm Cell Therapeutics, Inc. | -0.1928 |
| Kezar Life Sciences, Inc. | -0.7838 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -189.42M |
| Total Expenses (Quarterly) | 189.42M |
| Enterprise Value | 10.51B |
| Earnings Yield | -12.43% |
| Normalized Earnings Yield | -12.43 |